GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.

New guidelines for menopause treatment focus on hormone therapy and managing symptoms like hot flashes, sleep trouble, and depression.

FibroScan-aspartate aminotransferase may offer the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis.

Adding evolocumab to lipid-lowering therapy reduces all-cause mortality in high-risk patients without a history of myocardial infarction or stroke.

Among critically ill patients with acute kidney injury, intermittent hemodialysis as an initial treatment is not noninferior to CRRT.

Gossamer Bio has submitted a New Drug Application to the FDA seeking approval of seralutinib for pulmonary arterial hypertension (PAH).

Symptoms persist or become worse in more than a third of patients hospitalized due to heart failure, research shows.

There is an increased risk for incident MASLD associated with late-night eating, defined as eating after dinner or after bedtime.

Global myocarditis cases increased from 1990 to 2023, while age-standardized mortality and disability-adjusted life years saw significant declines.

A single partial-body amyloid PET scan can detect major types of cardiac amyloidosis even in early, low-burden ATTR, researchers have found.

Acute seizures occurring after pediatric ischemic stroke are strongly associated with an increased risk for subsequent poststroke epilepsy.

Post-hoc phase 2 data show coramitug induces an early, transient hsCRP rise followed by a sustained 52-week inflammatory reduction in ATTR-CM.